AAAAAA

   
Results: 1-25 | 26-50 | 51-56
Results: 1-25/56
Characterization of cytokine, growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor ALL
Authors: Kebelmann-Betzing, C Korner, G Badiali, L Buchwald, D Moricke, A Korte, A Kochling, J Wu, SL Kappelmeier, D Oettel, K Henze, G Seeger, K
Citation: C. Kebelmann-betzing et al., Characterization of cytokine, growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor ALL, CYTOKINE, 13(1), 2001, pp. 39-50
Absence of mutations in the CDKN2 binding site of CDK4 in childhood acute lymphoblastic leukemia
Authors: Einsiedel, HGV Taube, T Beyermann, B Dragon, S Moricke, A Kebelmann-Betzig, C Kochling, J Henze, G Seeger, K
Citation: Hgv. Einsiedel et al., Absence of mutations in the CDKN2 binding site of CDK4 in childhood acute lymphoblastic leukemia, LEUK LYMPH, 40(3-4), 2001, pp. 413
Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study
Authors: Paulussen, M Ahrens, S Lehnert, M Taeger, D Hense, HW Wagner, A Dunst, J Harms, D Reiter, A Henze, G Niemeyer, C Gobel, U Kremens, B Folsch, UR Aulitzky, WE Voute, PA Zoubek, A Jurgens, H
Citation: M. Paulussen et al., Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study, ANN ONCOL, 12(11), 2001, pp. 1619-1630
Treatment response and residual-disease monitoring in initial and relapsedTEL-AML1 positive childhood ALL
Authors: Seeger, K Viehmann, S Buchwald, D Harbott, J Schrappe, M Stary, J Henze, G Trka, J
Citation: K. Seeger et al., Treatment response and residual-disease monitoring in initial and relapsedTEL-AML1 positive childhood ALL, LEUKEMIA, 15(2), 2001, pp. 280-282
Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts
Authors: Wieder, T Prokop, A Bagci, B Essmann, F Bernicke, D Schulze-Osthoff, K Dorken, B Schmalz, HG Daniel, PT Henze, G
Citation: T. Wieder et al., Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts, LEUKEMIA, 15(11), 2001, pp. 1735-1742
Relapse of TEL-AML1-Positive acute lymphoblastic leukemia in childhood: A matched-pair analysis
Authors: Seeger, K Stackelberg, AV Taube, T Buchwald, D Korner, G Suttorp, M Dorffel, W Tausch, W Henze, G
Citation: K. Seeger et al., Relapse of TEL-AML1-Positive acute lymphoblastic leukemia in childhood: A matched-pair analysis, J CL ONCOL, 19(13), 2001, pp. 3188-3193
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: Results of study Acute Myeloid Leukemia - Berlin-Frankfurt-Munster 93
Authors: Creutzig, U Ritter, J Zimmermann, M Reinhardt, D Hermann, J Berthold, F Henze, G Jurgens, H Kabisch, H Havers, W Reiter, A Kluba, U Niggli, F Gadner, H
Citation: U. Creutzig et al., Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: Results of study Acute Myeloid Leukemia - Berlin-Frankfurt-Munster 93, J CL ONCOL, 19(10), 2001, pp. 2705-2713
Improved treatment results in children with AML: Results of study AML-BFM 93
Authors: Creutzig, U Berthold, F Boos, J Fleischhack, G Gadner, H Gnekow, A Graubner, U Henze, G Hermann, J Imbach, P Jurgens, H Kabisch, H Korholz, D Niemeyer, CM Reinhardt, D Reiter, A Ritter, J Spaar, HJ Zimmermann, M
Citation: U. Creutzig et al., Improved treatment results in children with AML: Results of study AML-BFM 93, KLIN PADIAT, 213(4), 2001, pp. 175-185
Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia
Authors: Eckert, C Biondi, A Seeger, K Cazzaniga, G Hartmann, R Beyermann, B Pogodda, M Proba, J Henze, G
Citation: C. Eckert et al., Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia, LANCET, 358(9289), 2001, pp. 1239-1241
The evaluation of the subtest "Labyrinthe" of the CFT 1
Authors: Dickhauser, O Schone, C Stiensmeier-Pelster, J Henze, G
Citation: O. Dickhauser et al., The evaluation of the subtest "Labyrinthe" of the CFT 1, DIAGNOSTICA, 47(1), 2001, pp. 40-42
Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by LightCycler technology
Authors: Wellmann, S Taube, T Paal, K von Einsiedel, MG Geilen, W Seifert, G Eckert, C Henze, G Seeger, K
Citation: S. Wellmann et al., Specific reverse transcription-PCR quantification of vascular endothelial growth factor (VEGF) splice variants by LightCycler technology, CLIN CHEM, 47(4), 2001, pp. 654-660
Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acutelymphoblastic leukemia (ALL)
Authors: Varon, R Reis, A Henze, G Von Einsiedel, HG Sperling, K Seeger, K
Citation: R. Varon et al., Mutations in the Nijmegen Breakage Syndrome gene (NBS1) in childhood acutelymphoblastic leukemia (ALL), CANCER RES, 61(9), 2001, pp. 3570-3572
Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerasechain reaction
Authors: Seeger, K Kreuzer, KA Lass, U Taube, T Buchwald, D Eckert, C Korner, G Schmidt, CA Henze, G
Citation: K. Seeger et al., Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerasechain reaction, CANCER RES, 61(6), 2001, pp. 2517-2522
Unusual T-cell receptor-delta gene rearrangement patterns revealed by screening of a large series of childhood acute lymphoblastic leukaemia by multiplex polymerase chain reaction
Authors: Seeger, K Taube, T Eckert, C Hanel, C Pogodda, M Henze, G
Citation: K. Seeger et al., Unusual T-cell receptor-delta gene rearrangement patterns revealed by screening of a large series of childhood acute lymphoblastic leukaemia by multiplex polymerase chain reaction, BR J HAEM, 113(2), 2001, pp. 318-322
Drug monitoring of low-dose PEG-asparaginase (Oncaspar (TM)) in children with relapsed acute lymphoblastic leukaemia
Authors: Pinheiro, JPV Muller, HJ Schwabe, D Gunkel, M da Palma, JC Henze, G von Schutz, V Winkelhorst, M Wurthwein, G Boos, J
Citation: Jpv. Pinheiro et al., Drug monitoring of low-dose PEG-asparaginase (Oncaspar (TM)) in children with relapsed acute lymphoblastic leukaemia, BR J HAEM, 113(1), 2001, pp. 115-119
Traumatic lumbar puncture at diagnosis and outcome in childhood acute lymphoblastic leukemia
Authors: Kebelmann-Betzing, C Seeger, K Wolf, R Henze, G
Citation: C. Kebelmann-betzing et al., Traumatic lumbar puncture at diagnosis and outcome in childhood acute lymphoblastic leukemia, BLOOD, 98(12), 2001, pp. 3496-3496
Prognostic value of p16(INK4a) gene deletions in pediatric acute lymphoblastic leukemia
Authors: Einsiedel, HG Taube, T Hartmann, R Eckert, C Seifert, G Wellmann, S Henze, G Seeger, K
Citation: Hg. Einsiedel et al., Prognostic value of p16(INK4a) gene deletions in pediatric acute lymphoblastic leukemia, BLOOD, 97(12), 2001, pp. 4002-4003
Expression analysis and characterization of alternatively spliced transcripts of human IL-7r alpha chain encoding two truncated receptor proteins in relapsed childhood ALL
Authors: Korte, A Kochling, J Badiali, L Eckert, C Andreae, J Geilen, W Kebelmann-Betzing, C Taube, T Wu, SL Henze, G Seeger, K
Citation: A. Korte et al., Expression analysis and characterization of alternatively spliced transcripts of human IL-7r alpha chain encoding two truncated receptor proteins in relapsed childhood ALL, CYTOKINE, 12(11), 2000, pp. 1597-1608
Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): Experience from the BFM trials
Authors: Seidemann, K Henze, G Beck, JD Sauerbrey, A Kuhl, J Mann, G Reiter, A
Citation: K. Seidemann et al., Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): Experience from the BFM trials, ANN ONCOL, 11, 2000, pp. 141-145
Childhood all blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID mice
Authors: Borgmann, A Baldy, C Von Stackelberg, A Beyermann, B Fichtner, I Nurnberg, P Henze, G
Citation: A. Borgmann et al., Childhood all blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID mice, PED HEM ONC, 17(8), 2000, pp. 635-650
Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo
Authors: Prokop, A Wieder, T Sturm, I Essmann, E Seeger, K Wuchter, C Ludwig, WD Henze, G Dorken, B Daniel, PT
Citation: A. Prokop et al., Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo, LEUKEMIA, 14(9), 2000, pp. 1606-1613
Potential of LightCycler technology for quantification of minimal residualdisease in childhood acute lymphoblastic leukemia
Authors: Eckert, C Landt, O Taube, T Seeger, K Beyermann, B Proba, J Henze, G
Citation: C. Eckert et al., Potential of LightCycler technology for quantification of minimal residualdisease in childhood acute lymphoblastic leukemia, LEUKEMIA, 14(2), 2000, pp. 316-323
Long-term results of four consecutive trials in childhood ALL performed bythe ALL-BFM study group from 1981 to 1995
Authors: Schrappe, M Reiter, A Zimmermann, M Harbott, J Ludwig, WD Henze, G Gadner, H Odenwald, E Riehm, H
Citation: M. Schrappe et al., Long-term results of four consecutive trials in childhood ALL performed bythe ALL-BFM study group from 1981 to 1995, LEUKEMIA, 14(12), 2000, pp. 2205-2222
20 years support for leukemia research in Germany
Authors: Henze, G
Citation: G. Henze, 20 years support for leukemia research in Germany, KLIN PADIAT, 212(4), 2000, pp. 137-138
Basic methods and the developing structure of a late effects surveillance system (LESS) in the long-term follow-up of pediatric cancer patients in Germany
Authors: Langer, T Henze, G Beck, JD
Citation: T. Langer et al., Basic methods and the developing structure of a late effects surveillance system (LESS) in the long-term follow-up of pediatric cancer patients in Germany, MED PED ONC, 34(5), 2000, pp. 348-351
Risultati: 1-25 | 26-50 | 51-56